Articles
Volume 9 Supplement 5
Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
- Reviews
- from Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
- $supplement.location
- $escapeTool.html($supplement.dateRange)
- Edited by John B Holcomb
- Supported by an educational grant from Novo Nordisk
|
Review
The epidemiology and modern management of traumatic hemorrhage: US and international perspectives David S Kauvar, Charles E Wade Critical Care 2005, 9(Suppl 5):S1-S9 (7 October 2005) |
|
Review
Optimizing the use of blood products in trauma care John R Hess, Seppo Hiippala Critical Care 2005, 9(Suppl 5):S10-S14 (7 October 2005) |
|
Review
Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma Anthony E Pusateri, Myung S Park Critical Care 2005, 9(Suppl 5):S15-S24 (7 October 2005) |
|
Review
Preclinical trauma studies of recombinant factor VIIa Martin A Schreiber, John B Holcomb, Rasmus Rojkjaer Critical Care 2005, 9(Suppl 5):S25-S28 (7 October 2005) |
|
Review
R Michael Grounds, Charles Bolan Critical Care 2005, 9(Suppl 5):S29-S36 (7 October 2005) |
|
Review
Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma Alicia M Mohr, John B Holcomb, Richard P Dutton, Jacques Duranteau Critical Care 2005, 9(Suppl 5):S37-S42 (7 October 2005) |
